ADHD, ADD: Clinical Trials

3 trials for ADHD, ADD, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 enrolling by invitation, 1 not yet recruiting. 2 Not applicable, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable2Enrolling by invitation 1, Not yet recruiting 1
Phase 31Completed 1

Follow ADHD, ADD: new trials by email Literature Review of ADHD, ADD trials Research Report on ADHD, ADD

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
The Primary Objective of This Study is to Determine Whether Positively Framed Information (PFI) on Side Effects, Compared to Negatively Framed and Extensive Information (NFI) Can Reduce the Number and Severity of Reported Adverse Events Caused by ADHD Medication in Children Aged 7 to 17 Years.
Communication Strategy for Side Effect Counseling in ADHD Treatment - Attention Deficit Disorder, Attention Deficit Disorder (ADD)
Not applicableNot yet recruitingSt. Antonius Hospital1302025-01-252025-01-28
Empowering Caregivers in ADHD Treatment: Standard Care Vs. Decision Aid, Coaching, and AI Support
Written Decision Aid, Decision Aid + Decision Coaching, AI-Driven Support - ADHD, ADHD, ADD
Not applicableEnrolling by invitationAriel University2002024-11-192025-02-17
Efficacy, Tolerability and Safety of Dexmethylphenidate HCl Extended-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder
Dexmethylphenidate HCl extended-release capsules - ADHD, ADD
Phase 3CompletedNovartis2522006-02-012007-12-21

Narrower conditions

Attention Deficit Disorder with Hyperactivity (3)  ·  Drug-Related Side Effects and Adverse Reactions (1)  ·  Medication Adherence (1)  ·  Patient Compliance (1)  ·  Spasm (1)

Broader conditions

Attention Deficit and Disruptive Behavior Disorders (3)  ·  Mental Disorders (3)  ·  Neurodevelopmental Disorders (3)  ·  Behavior (1)  ·  Chemically-Induced Disorders (1)  ·  Health Behavior (1)  ·  Nervous System Diseases (1)  ·  Neurologic Manifestations (1)  ·  Neuromuscular Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Patient Acceptance of Health Care (1)  ·  Signs and Symptoms (1)  ·  Treatment Adherence and Compliance (1)

Interventions

Decision Support Techniques (1)

Sponsors

Ariel University (1)  ·  Novartis (1)  ·  St. Antonius Hospital (1)

Countries

Israel (1)  ·  United States (1)

Top investigators

Arine Vlieger, MD, PhD (1)  ·  Yulia Gendler, PhD (1)